Dual CTLA-4 and PD-L1 Blockade Inhibits Tumor Growth and Liver Metastasis in a Highly Aggressive Orthotopic Mouse
E Fiegle1, D Doleschel2, S Koletnik1
1Institute for Experimental Molecular Imaging, Medical Faculty, RWTH Aachen University, Germany.
Abstract:
Immune checkpoint inhibitors have shown clinical benefit in several cancer entities including metastatic microsatellite instable colorectal carcinomas. However, for the majority of metastatic colorectal carcinomas the potential and limitations of immune checkpoint inhibition is not fully understood. In this study, the effects of sole and dual CTLA-4 and PD-L1 blockade were investigated in a microsatellite stable highly aggressive orthotopic mouse model of colon cancer. Dual CTLA-4 and PD-L1 inhibition resulted in tumor growth stagnation and completely blocked liver metastasis. Sole CTLA-4 and PD-L1 inhibition only moderately reduced metastatic spread of the colon cancer cells, though CTLA-4 blockade being superior to PD-L1 inhibition. Dual immune checkpoint blockade and sole CTLA-4 inhibition significantly increased intratumoral CD8+ and CD4+ T cells and reduced FOXP3+/CD4+ Treg cells. This was associated with increased expression levels of the pro-inflammatory Th1/M1-related cytokines IFN-γ, IL-1α, IL-2, and IL-12. Moreover, tumors treated with combined immune checkpoint blockade showed the strongest increase in intratumoral iNOS+ macrophages, reduction of PD-L1+ and Tie2+ macrophages and the lowest expression of M2/Th2-related IL-4, TARC and COX-2. The assessment of further microenvironmental changes by DCE-MRI and immunohistology revealed no alterations in functional tumor vascularization upon combined immune checkpoint blockade, but a significant increase in intratumoral fibroblasts and collagen I deposition. Thus, the synergistic inhibitory effects of dual immune checkpoint inhibition can be explained by anti-tumorigenic T cell responses mediated by CTLA-4 inhibition and M1 macrophage polarization predominantly induced by PD-L1 blockade. This was accompanied by pronounced fibroblast activation highlighting the interconnection between immunogenicity and desmoplasia.
Insights
Dual immune checkpoint blockade targeting CTLA-4 and PD-L1 significantly inhibited colon cancer growth and liver metastasis in mice. This approach enhanced anti-tumor T cells and M1 macrophages, demonstrating a promising strategy for aggressive colorectal cancers.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Immune checkpoint inhibitors (ICIs) offer clinical benefits in specific cancers like metastatic microsatellite instable colorectal carcinoma.
- The full potential and limitations of ICIs in the majority of metastatic colorectal carcinomas remain incompletely understood.
- Investigating novel therapeutic strategies is crucial for aggressive colon cancer subtypes.
Purpose of the Study:
- To evaluate the efficacy of sole and dual blockade of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed death-ligand 1 (PD-L1) in a mouse model of colon cancer.
- To elucidate the underlying mechanisms of immune response modulation and tumor microenvironment changes induced by these inhibitors.
Main Methods:
- Utilized a microsatellite stable, highly aggressive orthotopic mouse model of colon cancer.
- Administered sole and dual blockade of CTLA-4 and PD-L1.
- Assessed tumor growth, liver metastasis, immune cell infiltration (CD8+, CD4+, Treg), cytokine expression (IFN-γ, IL-1α, IL-2, IL-12, IL-4), macrophage polarization (iNOS+, PD-L1+, Tie2+), and tumor microenvironment characteristics (vascularization, fibroblasts, collagen I) via DCE-MRI and immunohistology.
Main Results:
- Dual CTLA-4 and PD-L1 blockade led to tumor growth stagnation and complete blockade of liver metastasis.
- Sole CTLA-4 inhibition was more effective than PD-L1 inhibition alone in reducing metastatic spread.
- Combined blockade significantly increased intratumoral CD8+ and CD4+ T cells, reduced regulatory T cells (Tregs), promoted M1 macrophage polarization, and increased fibroblast activation and collagen deposition, without altering tumor vascularization.
Conclusions:
- Dual CTLA-4 and PD-L1 blockade demonstrates synergistic anti-tumor effects in aggressive colon cancer.
- The efficacy is attributed to enhanced anti-tumorigenic T cell responses and M1 macrophage polarization, alongside increased fibroblast activation.
- This study highlights a promising combination immunotherapy strategy for microsatellite-stable colorectal cancer.
More Related Videos
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Related Concept Videos
Aggression
Neuromuscular Junction And Blockade
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Feedback Inhibition
The Colonization of Land
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
